首页> 外国专利> GPCR19 Composition for preventing or treating atopic dermatitis comprising GPCR19 agonist as an active ingredient

GPCR19 Composition for preventing or treating atopic dermatitis comprising GPCR19 agonist as an active ingredient

机译:GPCR19预防或治疗特应性皮炎的组合物,其包含GPCR19激动剂作为活性成分。

摘要

The present invention relates to a pharmaceutical composition, an oral preparation, an injectable preparation, and an external preparation and a cosmetic composition for prevention and improvement of atopy, which comprise GPCR19 agonist or sodium taurodeoxycholate and derivatives thereof as an active ingredient Which is superior to conventional steroid ointment and immunosuppressant ointment in the treatment and improvement of atopic dermatitis and directly reduces the amount of serum immunoglobulin IgE which is a main factor of atopic dermatitis, TH1 cytokine which alleviates the dermatitis pathology, reduces TH2 cytokine which exacerbates the pathology of atopic dermatitis, and reduces the infiltration of mast cells, eosinophils and neutrophils in dermal cells, thereby providing a pharmaceutical composition for prevention and treatment of atopy Can be utilized.
机译:预防和改善特应性的药物组合物,口服制剂,注射剂,外用制剂和化妆品组合物,其包含GPCR19激动剂或牛磺脱氧胆酸钠及其衍生物作为优于常规类固醇软膏和免疫抑制剂软膏用于特应性皮炎的治疗和改善,并直接降低血清免疫球蛋白IgE的含量,这是特应性皮炎的主要因素,TH1细胞因子减轻了皮炎的病理,降低了TH2细胞因子,加剧了特应性皮炎的病理并减少肥大细胞,嗜酸性粒细胞和嗜中性粒细胞在真皮细胞中的浸润,从而提供了可用于预防和治疗特应性的药物组合物。

著录项

  • 公开/公告号KR101998402B1

    专利类型

  • 公开/公告日2019-07-10

    原文格式PDF

  • 申请/专利权人 (주)샤페론;

    申请/专利号KR20140125691

  • 发明设计人 성승용;김연희;

    申请日2014-09-22

  • 分类号A61K31/56;A61K31/255;A61K8/63;A61K9/20;A61P17;A61Q19;

  • 国家 KR

  • 入库时间 2022-08-21 11:48:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号